The Edit Review: $209 Semaglutide, $309 Tirzepatide

The Edit (theedithealth.com) is a Texas-registered management services organization selling six compounded protocols, five of them injectable. We checked it in August 2026. It is the most price-transparent operator in a batch of seven telehealth sellers we screened together, and the reason is narrow and specific: two independent surfaces on its own site publish the same ladder, and every prepay figure divides correctly into the per-month figure printed beside it.

The ladder we filed

Semaglutide is $209 per month and tirzepatide is $309 per month on the month-to-month rung — the standing recurring rate, with no membership fee and cancellation at the end of the current period.¹ Prepay is offered at $575 once for three months of semaglutide ($192/month) and $1,065 once for six ($178/month); tirzepatide prepay is $855 for three months ($285/month) and $1,575 for six ($263/month).¹

Those prepay rungs are labeled "billed once at the start of the plan", and the divisions are honest: 575 ÷ 3 is 191.67, 1,065 ÷ 6 is 177.50, 855 ÷ 3 is 285, 1,575 ÷ 6 is 262.50. That sounds like faint praise until you see how often it goes the other way. The single most common way a provider ends up at the bottom of a price ranking is a prepay total presented as a monthly rate, and this ladder does not do it.

The number on the homepage is a promotion

The Edit advertises semaglutide at $109 and tirzepatide at $209 for a first order. That is a $100-off promotion on the first month, not a standing rate. If you are budgeting for six months of treatment, the numbers to use are $209 and $309, or the prepay totals above — not the promotional first month. We file the recurring rung for exactly this reason, and it is why our cheapest semaglutide ranking does not read like the ad copy on any provider's homepage.

The rest of the catalog

Beyond the two GLP-1 protocols, The Edit sells injectable NAD+ at $249/month, injectable glutathione at $199/month, injectable sermorelin at $169/month, and a GHK-Cu topical cream at $129/month.¹ There is no oral GLP-1, no nasal line, no retatrutide, and the site states in its own words that it does not sell research-use-only compounds — a sentence worth more than it looks, given how much of this market carries an investigational shelf beside the prescription one.

Who actually writes the prescription

The clinical work is done by Arora Health & Aesthetics, LLC, whose medical director is Dr. Sean Arora. His NPI, 1841729449, resolves in the national registry to an active Family Medicine record in Seattle, Washington.² Dispensing is attributed to The Pharmacy Hub, named on the site rather than described as an unnamed partner. Naming a prescriber and naming a pharmacy are the two checks in how to tell if a GLP-1 provider is legit that most of this cohort fails; The Edit passes both.

One thing readers should know before treating this as an independent second opinion: Trellis Vitality uses the same medical group and the same medical director. Different pharmacy, different prices, genuinely different products — but if you shortlist both, you are shortlisting one clinical organization twice, not comparing two.

The Spanish site is real

The Edit ships a complete Spanish mirror — every page, 33 Spanish URLs declared in its own sitemap. That is rare. Most operators in this market translate a landing page and stop, or run machine translation over an intake form. If Spanish is the language you want your medical instructions in, this is a material difference, not a marketing one.

The regulatory screen

We queried the FDA's live warning-letter index for the company, its legal entity, its medical group and its named pharmacy in August 2026. Nothing returned a match in the company column.³ That result only means something because the same pass, run the same way, correctly returned a known 2026 letter for an unrelated telehealth seller used as a positive control — an empty result from a broken query looks identical to a clean record, which is why the control matters.

What we could not verify

We could not reach a checkout price. The intake is a questionnaire-walled flow and its scripts carry no price table, so the ladder above is the published ladder, corroborated across two surfaces on the marketing site rather than confirmed at the point of sale. Compounded medication is final sale once shipped, which is standard across this category and explained in is compounded GLP-1 legit and safe. Getting started is free: the site states there is no charge and no card on file to begin, and a full refund if you are not approved.

Where it lands

If the thing you are optimizing for is a price you can trust to still be the price in month four, The Edit is the strongest of the seven providers in this batch. It is not the cheapest — Pepti at $99 and Trellis Vitality at $150 both undercut it on semaglutide, and Auren Rx undercuts it at $199. It is the one whose published numbers survived every arithmetic check we ran. Read that alongside the rest of our evidence library and the standing question set in how to choose a GLP-1 provider.